Prosecution Insights
Last updated: May 29, 2026

Examiner: HOERNER, PAUL ELLSWORTH

Tech Center 1600 • Art Units: 1611

This examiner grants 50% of resolved cases

Performance Statistics

50.0%
Allow Rate
-10.0% vs TC avg
107
Total Applications
+64.0%
Interview Lift
1305
Avg Prosecution Days
Based on 76 resolved cases, 2023–2026

Rejection Statute Breakdown

0%
§101 Eligibility
3.2%
§102 Novelty
65.6%
§103 Obviousness
3.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17602985 ENGINEERING A NATURALLY-DERIVED ADHESIVE AND CONDUCTIVE CARDIO-PATCH Non-Final OA THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
18257983 COSMETIC COMPOSITION COMPRISING A COMBINATION OF TWO PARTICULAR COUPLERS AND A NONIONIC SURFACTANT OF ALKYLPOLYGLYCOSIDE TYPE Non-Final OA L'OREAL
17819268 DRY LIPOSOME FORMULATIONS AND RELATED METHODS THEREOF Final Rejection BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
17311260 TOPICAL COMPOSITION COMPRISING VIABLE MICROORGANISMS Non-Final OA L'Oreal S.A.
18287762 CYCLOSPORINE COMPOSITIONS AND METHODS OF USE THEREOF Non-Final OA ProTransit Nanotherapy LLC
17774875 BIOMATERIALS FOR BONE TISSUE ENGINEERING Final Rejection University of Ottawa
17965738 ECHOGENIC COMPOSITIONS AND METHODS OF USE THEREOF FOR THE TREATMENT OF PAIN Non-Final OA InSitu Biologics, Inc.
17905618 METHOD FOR PRODUCING POLYMERSOMES Non-Final OA Heidelberg University
17662657 Neurosome/Astrosome Compositions and Methods of Use Final Rejection The Methodist Hospital

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month